Smart biosensors for cancer diagnosis based on graphene quantum dots

55Citations
Citations of this article
105Readers
Mendeley users who have this article in their library.

Abstract

The timely diagnosis of cancer represents the best chance to increase treatment success and to reduce cancer deaths. Nanomaterials-based biosensors containing graphene quantum dots (GQDs) as a sensing platform show great promise in the early and sensitive detection of cancer biomarkers, due to their unique chemical and physical properties, large surface area and ease of functionalization with different biomolecules able to recognize relevant cancer biomarkers. In this review, we report different advanced strategies for the synthesis and functionalization of GQDs with different agents able to selectively recognize and convert into a signal specific cancer bi-omarkers such as antigens, enzymes, hormones, proteins, cancer related byproducts, biomolecules exposed on the surface of cancer cells and changes in pH. The developed optical, electrochemical and chemiluminescent biosensors based on GQDs have been shown to ensure the effective diagnosis of several cancer diseases as well as the possibility to evaluate the effectiveness of anticancer therapy. The wide linear range of detection and low detection limits recorded for most of the re-ported biosensors highlight their great potential in clinics for the diagnosis and management of cancer.

Cite

CITATION STYLE

APA

Iannazzo, D., Espro, C., Celesti, C., Ferlazzo, A., & Neri, G. (2021, July 1). Smart biosensors for cancer diagnosis based on graphene quantum dots. Cancers. MDPI. https://doi.org/10.3390/cancers13133194

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free